Q2 2018 Holdings
Filed 2018-08-10 | 40 holdings | $254.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | ADR | 04351P101 | $144.1M | 2,166,832 | 56.7% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $44.0M | 3,054,825 | 17.3% |
| Aclaris Therapeutics(ACRS) | Common | 00461U105 | $32.9M | 1,647,214 | 12.9% |
| Arrowhead Pharmaceuticals In(ARWR) | Common | 04280A100 | $25.8M | 1,900,000 | 10.2% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $6.8M | 1,213,290 | 2.7% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $81.0K | 2,049,545 | 0.0% |
| Kadmon Holdings (Kdmn)(KDMN) | Common | 48283N106 | $68.9K | 10,454,545 | 0.0% |
| Menlo Therapeutics | Common | 586858102 | $32.6K | 4,011,236 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $32.0K | 1,456,499 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $29.7K | 991,711 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $28.8K | 1,409,742 | 0.0% |
| MEI Pharma Inc (NAS) | Common | 55279B202 | $26.0K | 6,600,660 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $21.9K | 1,791,257 | 0.0% |
| Amyris, Inc.(AMRSEUR) | Common | 03236M200 | $18.1K | 2,826,711 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $17.4K | 62,220 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $14.3K | 1,043,020 | 0.0% |
| Nabriva Therapeutics Plc | SHS | G63637105 | $14.2K | 4,074,190 | 0.0% |
| Obseva SA | Common | H5861P103 | $14.0K | 925,000 | 0.0% |
| Cymabay Therapeutics inc(CBAYUSD) | Common | 23257D103 | $12.2K | 906,000 | 0.0% |
| Strongbridge Biopharma plc | SHS USD | G85347105 | $11.5K | 1,918,132 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $10.3K | 780,601 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $10.2K | 4,359,683 | 0.0% |
| Deciphera Pharmaceuticals In(DCPHEUR) | Common | 24344T101 | $10.0K | 252,942 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $9.4K | 792,707 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $9.2K | 620,134 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $7.2K | 2,438,270 | 0.0% |
| Genocea Biosciences Inc(NMS) | Common | 372427104 | $7.0K | 8,180,000 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $5.9K | 82,403 | 0.0% |
| Zai Lab LTD(ZLAB) | ADR | 98887Q104 | $5.4K | 231,010 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $4.6K | 105,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $4.3K | 855,000 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $3.6K | 16,128,515 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $3.2K | 186,073 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $2.8K | 1,492,951 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $2.5K | 1,728,000 | 0.0% |
| KalVista Pharmaceuticals, Inc.(KALV) | Common | 483497103 | $2.4K | 300,325 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $742 | 1,513,975 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $674 | 345,850 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | $414 | 195,474 | 0.0% |
| Soleno Therapeutics, Inc. | Warrant | 834203135 | $79 | 188,772 | 0.0% |